DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Khorana AA, Soff GA, Kakkar AK. et al; CASSINI Investigators.
Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer.
N Engl J Med 2019;
380 (08) 720-728
We do not assume any responsibility for the contents of the web pages of other providers.